Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Hepatocellular Carcinoma
98%
Prevalence
96%
Neoplasm
92%
Atrial Fibrillation
87%
Odds Ratio
86%
Overall Survival
85%
Hazard Ratio
85%
Computer Assisted Tomography
77%
Cohort Analysis
72%
Lung
71%
Prognostic Factor
64%
Recurrent Disease
64%
Colonoscopy
58%
Colorectal Carcinoma
56%
Capsule Endoscopy
47%
Asthma
46%
Clinical Feature
44%
Progression Free Survival
44%
Body Mass Index
44%
Ulcerative Colitis
40%
Helicobacter Pylori
39%
Uric Acid
38%
Chronic Kidney Disease
38%
Inflammatory Bowel Disease
38%
Metabolic Syndrome
37%
Metastatic Carcinoma
37%
Lung Tuberculosis
36%
Adenoma
36%
Survival Rate
36%
Lung Cancer
34%
Non Small Cell Lung Cancer
34%
Cardiovascular System
31%
Apoplexy
31%
Rheumatoid Arthritis
31%
Inflammatory Arthritis
31%
Multiple Myeloma
30%
Diabetes Mellitus
30%
Diabetes
30%
Forced Expiratory Volume
30%
Hemodialysis
29%
Endoscopy
29%
Polycystic Ovary Syndrome
28%
Observational Study
28%
Crohn's Disease
28%
Blood Pressure
27%
Retrospective Study
27%
Fibrosis
27%
Prospective Study
26%
Reflux Esophagitis
25%
Kidney Function
25%
Biopsy Technique
24%
Meta-Analysis
24%
Enteropathy
24%
Combination Therapy
24%
Lymph Node Metastasis
24%
Bleeding
24%
Health Care Cost
24%
Elderly Patient
24%
Polyp
23%
Chronic Hepatitis B
23%
Persistent Atrial Fibrillation
23%
Vasculotropin
23%
functional dyspepsia
23%
Comorbidity
22%
Cross Sectional Study
22%
Coronary Artery Disease
22%
Breast Cancer
21%
Endothelial Cell
21%
Placebo
21%
Idiopathic Pulmonary Fibrosis
21%
Systolic Blood Pressure
21%
Diffuse Large B-Cell Lymphoma
21%
Patient with Inflammatory Bowel Disease
21%
Primary Tumor
21%
Hyperuricemia
21%
Endoscopic Ultrasound
21%
Retrospective Cohort Study
20%
Endoscopic Surgery
20%
Coughing
20%
Mesenchymal Stem Cell
20%
Peritoneal Dialysis
20%
Prospective Cohort Study
20%
Fluorodeoxyglucose F 18
19%
Colon
19%
Randomized Controlled Trial
19%
In Vitro
19%
Predictive Factor
19%
Patient Referral
19%
End Stage Renal Disease
19%
Treatment Response
18%
Low Drug Dose
18%
Messenger RNA
18%
Maturity Onset Diabetes of the Young
18%
Transcatheter Arterial Chemoembolization
18%
Patient with Crohn's Disease
18%
Insulin Resistance
18%
Liver Cirrhosis
18%
COVID-19
18%
Chronic Cough
18%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
95%
Prevalence
91%
Overall Survival
85%
Chronic Obstructive Lung Disease
81%
Asthma
81%
Uric Acid
71%
Neoplasm
67%
Cohort Study
60%
Atrial Fibrillation
51%
Recurrent Disease
49%
Progression Free Survival
47%
Clinical Feature
44%
Chronic Kidney Failure
43%
Diabetes Mellitus
42%
Helicobacter Pylori
39%
Placebo
39%
Hemodialysis
36%
Chronic Hepatitis B
35%
Inflammatory Bowel Disease
34%
Survival Rate
34%
Inflammatory Arthritis
33%
Rheumatoid Arthritis
33%
Colorectal Carcinoma
33%
Multiple Myeloma
32%
Non Small Cell Lung Cancer
32%
Combination Therapy
31%
Ulcerative Colitis
30%
Monotherapy
29%
Lung Cancer
29%
Crohn's Disease
28%
Prospective Study
27%
Hyperuricemia
26%
Kidney Disease
26%
Coughing
26%
Cisplatin
25%
Non Insulin Dependent Diabetes Mellitus
25%
Lung Tuberculosis
25%
Remission
25%
Acetylsalicylic Acid
25%
Fibrosis
24%
Metabolic Syndrome X
23%
Bleeding
23%
Chronic Cough
23%
Hepatitis B Virus
23%
Observational Study
23%
Cerebrovascular Accident
23%
Endothelial Dysfunction
22%
Comorbidity
21%
Inflammation
21%
End Stage Renal Disease
21%
Antibiotics
21%
Breast Cancer
21%
Sorafenib
21%
Hepatitis B
20%
Stomach Acid
20%
Biological Marker
20%
Bloodstream Infection
19%
Gemcitabine
19%
Retrospective Study
18%
Coronary Artery Disease
18%
Prospective Cohort Study
18%
C Reactive Protein
18%
Anticoagulant Agent
18%
Tumor Necrosis Factor
18%
Adenoma
18%
Fluorouracil
18%
Clinical Study
17%
Cytokine
17%
All Cause Mortality
17%
Disease Activity
17%
Paclitaxel
17%
Capecitabine
17%
Randomized Controlled Trial
17%
Mortality Rate
16%
Syndrome
16%
Oxaliplatin
16%
Liver Cirrhosis
16%
Messenger RNA
16%
Reflux Esophagitis
16%
Nitric Oxide
15%
Imatinib
15%
Antiinfective Agent
15%
Gastrointestinal Hemorrhage
15%
Docetaxel
15%
Metastatic Colorectal Cancer
15%
Fibrosing Alveolitis
15%
Staphylococcus Aureus
15%
Bronchodilating Agent
14%
Insulin Resistance
14%
Disease Exacerbation
14%
Persistent Atrial Fibrillation
14%
Disease Course
14%
Dexamethasone
14%
Heart Infarction
14%
Phase II Trials
14%
Epidermal Growth Factor Receptor
13%
Normal Human
13%
Doxorubicin
13%
Colitis
13%
Receptor
13%
Immunology and Microbiology
Asthma
73%
Prevalence
43%
Overall Survival
38%
Inflammatory Bowel Disease
33%
Multiple Myeloma
29%
Inflammatory Arthritis
28%
Body Mass
25%
Forced Expiratory Volume
25%
Airway
24%
Crohn's Disease
23%
Staphylococcus Aureus
23%
B Cell
23%
Ulcerative Colitis
21%
Neutrophil
20%
Computer Assisted Tomography
20%
Colon
20%
Severe Asthma
19%
Progression Free Survival
19%
Hepatitis B
19%
Cytokine
19%
C-Reactive Protein
19%
Mesenchymal Stem Cell
17%
T Cell
16%
Hemodialysis
16%
Colitis
16%
Coronary Artery
15%
Microorganism
14%
Tonsil
14%
Single Nucleotide Polymorphism
14%
Survival Rate
14%
Methicillin-Resistant Staphylococcus Aureus
14%
Epithelial Mesenchymal Transition
13%
Myeloid
13%
Forced Vital Capacity
12%
Dexamethasone
12%
Tumor Necrosis Factor
12%
Angiogenesis
12%
Programmed Cell Death
12%
Kidney Transplantation
11%
Cancer Cell
11%
Human Immunodeficiency Virus
11%
Infectious Agent
11%
Autologous Stem Cell Transplantation
11%
Allergen
11%
Cell Proliferation
10%
Blood Level
10%
Interferon Type I
10%
Hepatitis B Virus
10%
Comorbidity
10%
Oxidative Stress
10%
Lung Function
10%
Blood Pressure
10%
Thalidomide
10%
Blood Plasma
9%
Lymphocyte
9%
Albumin
9%
Allograft
9%
Cancer Growth Factor
9%
Bronchodilator
9%
Mortality Rate
9%
Sputum
9%
Interleukin 6
9%
Eosinophil
9%
Airflow
9%
Interleukin 10
9%
Systemic Lupus Erythematosus
8%
Recurrence Free Survival
8%
Immunoglobulin E
8%
Hepatocyte Growth Factor
8%
Fibrinogen
8%
Drug Megadose
8%
Normal Human
7%
Peritoneal Dialysis
7%
Hepatitis B Antigen
7%
HBsAg
7%
Tumor Necrosis Factor Alpha
7%
Respiratory Tract Allergy
7%
Titer
7%
Creatinine Blood Level
7%
Macrophage
7%
Interleukin 2
7%
Protein Expression
7%
Interleukin 17
7%
Helicobacter Pylori
7%
Insulin Resistance
7%
High Risk Population
7%
Interleukin 4
7%
Lenalidomide
7%
Systolic Blood Pressure
6%
Umbilical Cord Blood
6%
Extracellular Matrix
6%
Allele
6%
Hypersensitive Response
6%
down Regulation
6%
Hypersensitivity
6%
Arm
6%
Arterial Stiffness
6%
TLR2
6%
Intestine Flora
6%
Mouse Model
6%